CAMP4 Historical Cash Flow
| CAMP Stock | USD 4.91 1.16 30.93% |
Analysis of CAMP4 THERAPEUTICS cash flow over time is an excellent tool to project CAMP4 THERAPEUTICS future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Begin Period Cash Flow of 99.6 M or Depreciation of 1.4 M as it is a great indicator of CAMP4 THERAPEUTICS ability to facilitate future growth, repay debt on time or pay out dividends.
CAMP4 |
About CAMP4 Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in CAMP4 balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which CAMP4's non-liquid assets can be easily converted into cash.
CAMP4 THERAPEUTICS Cash Flow Chart
Add Fundamental
Stock Based Compensation
Compensation provided to employees in the form of equity or options to purchase company stock. This type of compensation is used to align the interests of employees and shareholders.Begin Period Cash Flow
The amount of cash a company has at the beginning of a financial reporting period. It serves as the starting point for calculating the period's cash flow from operations, investing, and financing activities.Capital Expenditures
Capital Expenditures are funds used by CAMP4 THERAPEUTICS to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of CAMP4 THERAPEUTICS operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.Most accounts from CAMP4 THERAPEUTICS's cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into CAMP4 THERAPEUTICS current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CAMP4 THERAPEUTICS PORATION. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. At this time, CAMP4 THERAPEUTICS's Begin Period Cash Flow is relatively stable compared to the past year. As of 03/02/2025, Total Cash From Financing Activities is likely to grow to about 363.5 K, while Stock Based Compensation is likely to drop slightly above 2.5 M.
| 2022 | 2023 | 2024 | 2025 (projected) | Other Non Cash Items | 2.0M | 1.8M | 1.6M | 1.6M | Depreciation | 21.8M | 1.7M | 1.5M | 1.4M |
CAMP4 THERAPEUTICS cash flow statement Correlations
Click cells to compare fundamentals
CAMP4 THERAPEUTICS Account Relationship Matchups
High Positive Relationship
High Negative Relationship
CAMP4 THERAPEUTICS cash flow statement Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Change In Cash | (12.8M) | (15.4M) | (37.3M) | (44.5M) | (51.2M) | (53.8M) | |
| Stock Based Compensation | 11.4M | 11.3M | 10.2M | 2.9M | 2.6M | 2.5M | |
| Free Cash Flow | 17.2M | (17.5M) | (34.0M) | (44.8M) | (40.3M) | (38.3M) | |
| Change In Working Capital | 14.9M | (17.4M) | (25.1M) | (1.3M) | (1.1M) | (1.2M) | |
| Begin Period Cash Flow | 107.4M | 94.6M | 79.2M | 84.5M | 76.1M | 99.6M | |
| Depreciation | 22.0M | 22.8M | 21.8M | 1.7M | 1.5M | 1.4M | |
| Other Non Cash Items | 1.4M | 9.8M | 2.0M | 1.8M | 1.6M | 1.6M | |
| Capital Expenditures | 11.4M | 13.3M | 11.1M | 678K | 610.2K | 579.7K | |
| Total Cash From Operating Activities | 28.6M | (4.2M) | (22.9M) | (44.2M) | (39.7M) | (37.8M) | |
| Net Income | (21.2M) | (31.1M) | (32.5M) | (49.3M) | (56.7M) | (59.5M) | |
| Total Cash From Financing Activities | (27.3M) | (2.6M) | (909K) | 301K | 346.2K | 363.5K | |
| End Period Cash Flow | 94.6M | 79.2M | 41.9M | 40.0M | 36.0M | 58.1M |
Additional Tools for CAMP4 Stock Analysis
When running CAMP4 THERAPEUTICS's price analysis, check to measure CAMP4 THERAPEUTICS's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CAMP4 THERAPEUTICS is operating at the current time. Most of CAMP4 THERAPEUTICS's value examination focuses on studying past and present price action to predict the probability of CAMP4 THERAPEUTICS's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CAMP4 THERAPEUTICS's price. Additionally, you may evaluate how the addition of CAMP4 THERAPEUTICS to your portfolios can decrease your overall portfolio volatility.